Revvity price target lowered to $147 from $165 at Baird

Baird analyst Catherine Ramsey Schulte lowered the firm’s price target on Revvity to $147 from $165 and keeps an Outperform rating on the shares. The firmt expects its base (non-COVID) business to grow mid-single-digits for the full year, a better outlook than the other covered tools names that have reported thus far. Baird is taking a more cautious view on the mid-term outlook, but thinks the company is starting to show the uniqueness of its new portfolio and continue to find the mid-term outlook attractive at current valuation.